I was tagged in a post a number of times and thought that I would do a little 🧵. Several months ago, I began to observe the similarities between the pathophysiology of a chronic HIV and SARS-Cov-2 infection.
It was at that time that I performed a great deal of study into molecular docking studies involving Gilead's portfolio. They are the largest manufacturer of first line HIV medications in the country. I didn't fool with Pfizer because they make salvage drugs, lol.
The molecular docking studies that I read revealed that within Gilead's portfolio is what is described as a Double Nuke. A Double Nuke refers to two Nucleoside Reverse Transcriptase Inhibitors.
I forgot to mention that Azvudine belongs to the same class! That double nuke is sold under the name of Truvada and is used to prevent the acquisition of HIV.
Tenofovir Disoproxil Fumarate has demonstrated the ability to interfere with MPro, 3ClPro, and prevent S Protein/ACE-2 Binding.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
As the Founder of SARS-Cov-2 Associated Neurocognitive Decline (SAND) Scan, I am going to once again say that my clients do not suffer from g****** brain fog. Time for another 🧵
@loscharlos Unfortunately, there appears to be a huge misunderstanding as to what is required to initiate/maintain antivirals and what this virus does to the body.
@loscharlos Because of the method in which it infects the host, the virus damages both the liver and kidneys, critically important to metabolize/excrete antivirals. The virus causes osteoporosis through infected monocyte derived macrophages differentiating into osteoclasts.
@loscharlos These osteoclssts tear bone down faster than it can be laid down by osteoblasts. This is why teeth are falling out and jaws sre disintegrating. The mandible is rich in osteoclasts.
Damnit, Goodyear rejected my job application. So much for reinventing the wheel. Instead, I will report on the Texan With Tunneling Nanotubes. FYI, any personal information disclosed in the Tweet is in the Zoom Recording.
The Texan is a 48 YO Caucasian male whose first Estimated Date of Seroconversion was in December, 2019. His second Estimated Date of Seroconversion was in January, 2022. He reports not having lost his sense of smell nor taste.
Having not lost the sense of smell is extremely important, given what we know about this virus and Alzheimer's Disease.
@EurekaHealthApp@CassandraNoCov Several months ago, I interacted with a client who complained of "brain fog." His suffering led me to engage in research into the issue. This is the first article that I came across. ucsf.edu/news/2022/01/4…
I just got off the phone with someone who invited me to participate in their life in an intimate way. They were curious about the use of Nitric Oxide.
Wanted to provided this short writeup considering people are talking about endothelial damage and are thinking Paxlovid might be something worth trialing.
It ain't brain fog. It is SARS-Cov-2 Associated Neurocognitive Decline (SAND) and we are not moving fast enough. nbcnews.com/health/health-…
Where did I come up with SARS-Cov-2 Associated Neurocognitive Decline? I just substituted SARS-Cov-2 for HIV. They use the same mechanism for what is referred to as reservoir "seeding." science.org/doi/10.1126/sc…
There are a number of very compelling reasons why SARS-Cov-2 Associated Neurocognitive Decline should be managed as if it were HIV Associated Neurocognitive Decline. The primary being that CD4 apoptosis, or death, is observed in both infections.